The White House laid out a plan on Monday to share 55 million U.S. COVID-19 vaccine doses globally, with roughly 75% of the doses allocated to Latin America and the Caribbean, Asia and Africa through the COVAX international vaccine-sharing program.
Cuba said on Monday its three-shot Abdala vaccine against the coronavirus had proved 92.28% effective in last-stage clinical trials.